Atlanta—Therapeutic advances in recent years have beaten back and even defeated hematologic cancers in many patients, yet oncologists note that poor prognoses and cancer death rates remain significant. At the 49th Annual Meeting of the American Society of Hematology, held here in December, researchers discussed some of the latest efforts to advance the treatment of hematologic cancers, including Hodgkin and non-Hodgkin lymphomas, leukemia, and multiple myeloma.
Graphic Jump Location
Researchers are testing new agents that attack malignant cells of non-Hodgkin lymphoma and other hematologic cancers.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.